Consensus Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
34.06 ^USD	+14.07%		+3.65%	-17.13%

May. 14	Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024
May. 13	Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down	MT

Evolution of the average Target Price on Sanara MedTech Inc.

Price target over the last 5 years

History of analyst recommendation changes

b96f116ee4cbc739.T1pquDvGsuyMqMqkz0vo5jXXEvR3_gauLQ4qW5oUqa4.ATwl4Uj--La_76PVhh-wtXGTZ6wPzjH5aj9uN65QhOAZK1LpcJf8j-3PpQ~3808f1cd3ee20e3884ca93a8ca7a733f

Analyst Recommendations on Sanara MedTech Inc.

Cantor Fitzgerald Cuts Price Target on Sanara MedTech to $44 From $49, Maintains Overweight Rating	Mar. 27	MT
Cantor Fitzgerald Adjusts Price Target on Sanara MedTech to $49 From $59, Maintains Overweight Rating	Nov. 15	MT
SANARA MEDTECH : Cantor Fitzgerald Starts Sanara MedTech at Overweight With $45 Price Target	21-06-30	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

29.86 USD

Average target price

44 USD

Spread / Average Target

+47.35%

High Price Target

44 USD

Spread / Highest target

+47.35%

Low Price Target

44 USD

Spread / Lowest Target

+47.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sanara MedTech Inc.

Cantor Fitzgerald

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar